Changes and trends in medication-assisted treatment in Israel

Israel Journal of Health Policy Research

Original Research Article

Iris Levy¹  Adi Marom²  Paola Rosca³ 

[1] Department for the Treatment of Substance Abuse, Israeli Ministry of Health, 39 Yirmiyahu St., 9446724, Jerusalem, Israel;The Hebrew University- Hadassah Medical School, Campus Ein Kerem, 9112102, Jerusalem, Israel;The Hebrew University- Hadassah Medical School, Campus Ein Kerem, 9112102, Jerusalem, Israel;Department for the Treatment of Substance Abuse, Israeli Ministry of Health, 39 Yirmiyahu St., 9446724, Jerusalem, Israel;

关键词: Opioid use disorder;    Opioid maintenance treatment;    Opioid agonist therapy;    Medication assisted treatment;   

DOI  :  10.1186/s13584-022-00551-8

 received in 2022-01-18, accepted in 2022-12-27,  发布年份 2022

来源: Springer

【 摘 要 】

BackgroundAs opioid prescription in Israel is increasing, there is a growing need for monitoring opioid use disorder and providing opioid agonist therapy. Our goal is to describe, sub-analyze, and identify obstacles in the treatment of opioid misuse in the Israeli medication assisted treatment centers.MethodsData on methadone, buprenorphine, and buprenorphine combined with naloxone for the indication of opioid addiction treatment for the period 2013–2020 were obtained from pharmaceutical companies that distribute them in Israel. Data on utilization of these drugs were also extracted from the database maintained by the Israel Ministry of Health's Pharmaceutical Administration Division. The data were converted to defined daily doses (DDD)/1000 inhabitants/day.ResultsThe number of patients receiving medication assisted treatment increased by 10% since 2013, with a shift from buprenorphine alone to buprenorphine/naloxone in government-run centers. Methadone remains the most popular maintenance drug.ConclusionsThe change in opioid maintenance prescription does not match the significant increase in opioid consumption. Optimization of treatment can be achieved by the creation of a comprehensive database, cooperation between healthcare organizations and the government and further development of non-stigmatic and accessible services.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

41116_2022_35_Article_IEq387.gif

Fig. 2